Psychiatric Polypharmacy, Etiology and Potential Consequences

Publisher： Bentham Science Publishers

E-ISSN： 2211-5579|6|1|12-26

ISSN： 2211-5560

Source： Current Psychopharmacology, Vol.6, Iss.1, 2017-04, pp. : 12-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical consequences of polypharmacy in elderly

By Maher Robert L   Hanlon Joseph   Hajjar Emily R  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 57-65

Informa Healthcare

Access to resources Recommend Favorite

Reasons for polypharmacy among psychiatric patients

By Viola Réka   Csukonyi Katalin   Doró Péter   Janka Zoltán   Soós Gyöngyvér  

Pharmacy World and Science, Vol. 26, Iss. 3, 2004-06 ,pp. : 143-147

Springer Publishing Company

Access to resources Recommend Favorite

Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan: A Retrospective Computerized Screening Study

By Lin Chen-Fang   Wang Chun-Yu   Bai Chyi-Huey  

Drugs & Aging, Vol. 28, Iss. 3, 2011-03 ,pp. : 219-225

Adis International

Access to resources Recommend Favorite

Antipsychotic Polypharmacy

By  

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2231-2238

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro Metabolism of Phenstatin: Potential Pharmacological Consequences

By  

Drug Metabolism Letters, Vol. 5, Iss. 3, 2011-08 ,pp. : 209-215

Bentham Science Publishers

Access to resources Recommend Favorite